Acute Porphyria Drug Database

Monograph

B01AD07 - Reteplase
Not porphyrinogenic
NP

Rationale
Recombinant enzyme. No CYP-interactions.
Chemical description
Recombinant enzymatic plasmin activator administered as infusion within 12 hour after herat infarction.

Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Rapilysin · Rapilysin 10 U, poeder voor injectievloeistof 10 U
United Kingdom
Rapilysin · Rapilysin 10unit powder and solvent for solution for injection vials
Denmark
Rapilysin
Poland
Rapilysin
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙